Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boswellia Carterii Extract Combined With Structured Patient Education in IBS
NCT07576634Phase 3Completed
- Sponsor
- Mansoura University
- Start
- Jan 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of boswellia carterii extract in irritable bowel syndrome (IBS), sponsored by Mansoura University. Primary endpoint: Effects of standardized Boswellia extract on irritable bowel syndrome patients at 1 month. Started Jan 2025; status: completed.
02
Drugs
boswellia carterii extract
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT07576634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07576634.